Seelos Therapeutics is preparing to conduct a global study investigating its intranasal racemic ketamine SLS-002, CEO Dr Raj Mehra told Clinical Trials Arena. The Phase III trial will enrol adult patients with acute suicidal ideation and behaviour (ASIB) in major depressive disorder (MDD). The global trial will include patients from Asian countries, Western Europe and likely […]

Nearly half of all heart attacks are “silent,” which means the person experiences no symptoms at all before the cardiac event, studies have shown. Now a medical technology company aims to catch those pre-symptomatic heart conditions using the power of artificial intelligence.

The recent FDA approval of Leqembi, the latest anti-amyloid drug, is undoubtedly a breakthrough for the field, providing a new way to slow the advancement of mild cognitive impairment or early-stage Alzheimer’s disease. As a practicing geriatrician who has treated Alzheimer’s patients for more than 40 years and the co-founder and chief science officer at the Alzheimer’s Drug […]